Andrew Ferrier - Bunge Independent Director
| BG Stock | USD 109.52 3.01 2.83% |
Director
Mr. Andrew Alan Ferrier is an Independent Director of Bunge Limited, Mr. Ferrier was a member of our Board since 2012. He is Executive Chairman of Canz Capital Limited, a private investment company he founded in 2011. He served as Chief Executive Officer of Fonterra Cooperative Group Ltd., a leading New Zealandbased international dairy company, from 2003 to 2011. Previously, he served as President and Chief Executive Officer of GSW Inc., a Canadian consumer durable goods manufacturer, from 2000 to 2003. Prior to 2000, Mr. Ferrier spent 16 years in the sugar industry working in Canada, the United States, the United Kingdom and Mexico. From 1994 to 1999, Mr. Ferrier worked for Tate Lyle, first as President of Redpath Sugars and subsequently as President and Chief Executive Officer of Tate Lyle North America Sugars Inc. Mr. Ferrier has served as Chairman of New Zealand Trade and Enterprise, the national economic development agency, since November 2012 and since October 2014 was Chairman of Orion Health Ltd. He also serves as a councillor of the University of Auckland. since 2012.
| Age | 60 |
| Tenure | 12 years |
| Address | 1391 Timberlake Manor Parkway, Chesterfield, MO, United States, 63017 |
| Phone | 314 292 2000 |
| Web | https://www.bunge.com |
Bunge Management Efficiency
The company has Return on Asset (ROA) of 0.0819 % which means that for every $100 of assets, it generated a profit of $0.0819. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.2147 %, which means that it produced $0.2147 on every 100 dollars invested by current stockholders. Bunge's management efficiency ratios could be used to measure how well Bunge manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bunge's Return On Equity is most likely to increase slightly in the upcoming years. At this time, Bunge's Return On Tangible Assets are most likely to increase slightly in the upcoming years. The Bunge's current Debt To Assets is estimated to increase to 0.30, while Other Assets are projected to decrease to roughly 1.1 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jonathan Mariner | Tyson Foods | 66 | |
| Sherman Miller | Cal Maine Foods | 49 | |
| Barbara Tyson | Tyson Foods | 71 | |
| Jim Anderson | Adecoagro SA | 60 | |
| Mark Schachter | Adecoagro SA | 40 | |
| David Bronczek | Tyson Foods | 66 | |
| Jeffrey Schomburger | Tyson Foods | 58 | |
| Gaurdie Banister | Tyson Foods | 62 | |
| Walter Sanchez | Adecoagro SA | 51 | |
| Mario Imbrosciano | Adecoagro SA | 50 | |
| Andres Branes | Adecoagro SA | 58 | |
| Les Baledge | Tyson Foods | 61 | |
| Paulo Vieira | Adecoagro SA | 45 | |
| Mike Beebe | Tyson Foods | 74 | |
| Robert Thurber | Tyson Foods | 72 | |
| Julio Moura | Adecoagro SA | 62 | |
| Brad Sauer | Tyson Foods | 55 | |
| Timothy Dawson | Cal Maine Foods | 62 | |
| Letitia Hughes | Cal Maine Foods | 64 | |
| Mikel Durham | Tyson Foods | 57 | |
| Cheryl Miller | Tyson Foods | 48 | |
Management Performance
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.0819 |
Bunge Limited Leadership Team
Elected by the shareholders, the Bunge's board of directors comprises two types of representatives: Bunge inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bunge. The board's role is to monitor Bunge's management team and ensure that shareholders' interests are well served. Bunge's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bunge's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bernardo Hees, Independent Director | ||
| Kellie Sears, Chief Officer | ||
| Tommy Jensen, CEO, Bunge Europe, Middle East & Africa | ||
| Vinita Bali, Independent Director | ||
| Frank Jimenez, General Counsel, Managing Director - Government Affairs, Secretary | ||
| J Fyrwald, Independent Director | ||
| Bernard Lauraguais, Independent Director | ||
| Brian Thomsen, Managing Director of Bunge Global Agribusiness and CEO of Bunge Product Lines | ||
| Robert Coviello, Executive Vice President and Chief Growth and Strategy Officer | ||
| Andrew Ferrier, Independent Director | ||
| Brian Zachman, President of Global Risk Management | ||
| Julio Garros, President Agribusiness Development, Operations and Milling | ||
| Raul Padilla, Managing Director of Sugar and Bioenergy and CEO of Bunge Brazil | ||
| Thomas Boehlert, CFO, Executive Vice President | ||
| Mark Zenuk, Independent Director | ||
| John McGlade, Independent Director | ||
| Mark Haden, IR Contact Officer | ||
| Deborah Borg, Executive Vice President and Chief Humar Resource and Communications Officer | ||
| Patrick Lupo, Non-Executive Chairman of the Board | ||
| Aaron Buettner, President - Bunge Loders Croklaan | ||
| L Lupo, Non-Executive Independent Chairman of the Board | ||
| Debra King, Chief Officer | ||
| David Kabbes, Executive Vice President - Corporate Affairs and Chief Legal Officer | ||
| Carol Browner, Independent Director | ||
| Michael Goettl, CEO, Bunge Asia | ||
| Erik Fyrwald, Director | ||
| Robert Wagner, Chief Risk Officer | ||
| Enrique Humanes, CEO, Bunge Argentina | ||
| Matt Simmons, Controller, Principal Accounting Officer | ||
| Soren Schroder, CEO and Director | ||
| Kenneth Simril, Independent Director | ||
| Joseph Podwika, Executive Vice President and Chief Legal Officer | ||
| Haden Mark, IR Contact Officer | ||
| Jay Winship, Independent Director | ||
| Henry Winship, Independent Director | ||
| Gordon Hardie, Managing Director of Food and Ingredients | ||
| Paul WaysRuart, Independent Director | ||
| Christos Dimopoulos, President - Global Supply Chains | ||
| Gregory Heckman, Chief Executive Officer, Director | ||
| Ruth Wisener, Vice President of Investor Relations | ||
| John Neppl, Chief Financial Officer, Executive Vice President | ||
| Michael Kobori, Independent Director | ||
| Andreas Fibig, Director | ||
| Kathleen Hyle, Independent Chairman of the Board | ||
| Pierre Mauger, Chief Development and Performance Management Officer | ||
| Ernest Bachrach, Independent Director | ||
| William Engels, Independent Director | ||
| Paul Fribourg, Independent Director | ||
| Jerry Simmons, Principal Controller | ||
| Sheila Bair, Independent Vice Chairman of the Board | ||
| Enrique Boilini, Independent Director | ||
| Todd Bastean, CEO, Bunge North America | ||
| Andrew Burke, CFO and Global Operational Excellence Officer | ||
| John CPA, Executive CFO |
Bunge Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bunge a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.0819 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 18.92 B | ||||
| Shares Outstanding | 140.98 M | ||||
| Shares Owned By Insiders | 0.72 % | ||||
| Shares Owned By Institutions | 90.85 % | ||||
| Number Of Shares Shorted | 5.2 M | ||||
| Price To Earning | 10.36 X |
Pair Trading with Bunge
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bunge position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bunge will appreciate offsetting losses from the drop in the long position's value.Moving together with Bunge Stock
| 0.71 | K | Kellanova Earnings Call This Week | PairCorr |
| 0.66 | MO | Altria Group Earnings Call This Week | PairCorr |
Moving against Bunge Stock
| 0.91 | HPCO | Hempacco Report 10th of May 2024 | PairCorr |
| 0.89 | ISPR | Ispire Technology Common | PairCorr |
| 0.84 | PAVS | Paranovus Entertainment | PairCorr |
| 0.77 | SAM | Boston Beer Earnings Call This Week | PairCorr |
| 0.75 | BUD | Anheuser Busch Inbev Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Bunge could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bunge when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bunge - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bunge Limited to buy it.
The correlation of Bunge is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bunge moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bunge Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bunge can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bunge Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Bunge Limited information on this page should be used as a complementary analysis to other Bunge's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Bunge Stock analysis
When running Bunge's price analysis, check to measure Bunge's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bunge is operating at the current time. Most of Bunge's value examination focuses on studying past and present price action to predict the probability of Bunge's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bunge's price. Additionally, you may evaluate how the addition of Bunge to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Bunge's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bunge. If investors know Bunge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bunge listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.898 | Dividend Share 2.613 | Earnings Share 14.86 | Revenue Per Share 400.123 | Quarterly Revenue Growth (0.10) |
The market value of Bunge Limited is measured differently than its book value, which is the value of Bunge that is recorded on the company's balance sheet. Investors also form their own opinion of Bunge's value that differs from its market value or its book value, called intrinsic value, which is Bunge's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bunge's market value can be influenced by many factors that don't directly affect Bunge's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bunge's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bunge is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bunge's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.